COVID-19 Vaccines in Children and Teens with IBD

Watch our latest webinar to get updates and guidance on COVID-19 vaccines in children and teens living with Crohn's or colitis. Topics include vaccine efficacy, antibody response, vaccine safety, potential risks or side effects, timing of doses, and the impact of IBD medications and disease severity.

 

Featured Panelists

Dr. Kevan Jacobson (MD, FACP, MBBCH, FRCPC), Professor and Senior Clinician Scientist, Department of Pediatrics, Child and Family Research Institute, BC Children’s Hospital

Dr. Anne Pham-Huy (MD, FRCPC) Assistant Professor, Department of Pediatrics, University of Ottawa, Physician Lead, Primary Immunodeficiency Clinic and Pediatric Infectious Diseases Consultant, Program Director of the Pediatric Infectious Diseases Training Program, Children’s Hospital of Eastern Ontario (CHEO), Chair of Immunize Canada

Dr. David Mack (MD, FRCPC), Professor and Gastroenterologist, University of Ottawa and Director, CHEO IBD Centre, Division of Gastroenterology, Hepatology & Nutrition

Moderators

Dr. Gilaad Kaplan (MD, MPH, FRCPC), Professor of Medicine, Gastroenterologist and Epidemiologist, Departments of Medicine and Community Health Sciences, University of Calgary, Past Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada l Twitter: @gilkaplan

Dr. Eric Benchimol (MD, PhD, FRCPC), Professor, Pediatric Gastroenterologist, Department of Paediatrics, The Hospital for Sick Children (SickKids) and University of Toronto, Division of Gastroenterology, Hepatology and Nutrition, SickKids, NASPGHAN Canadian Councilor, Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada | Twitter: @ericbenchimol

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.